Pipeline

Ipsen’s R&D activities are focused on the discovery and development of new molecules and on programs for the lifecycle management of products already marketed by the group (new formulations, extension of indications and registration of products in new geographical areas). Download here the pipeline updated at March 31, 2016.

Oncology
Preclinical
Phase I
Phase II
Phase III
-
-
-
-
-
NOVEL RADIOPHARMACEUTICALS
(Licensed from 3B Pharma)
In progress in 2015
-
-
-
PEPTIDE RECEPTOR RADIONUCLIDE THERAPY
177LU-OPS201
In progress in 2015
-
-
-
TRANSMEMBRANE ONCOLOGY TARGET
In progress in 2015
-
-
-
INTRACELLULAR ONCOLOGY TARGET
In progress in 2015
-
-
-
68GA-OPS202
Diagnostic agent for NET
-
-
Completed in 2015/Early 2016
-
CABOZANTINIB
Renal cell carcinoma (First line) (Partnership with Exelixis)
-
-
In progress in 2015
-
TELOTRISTAT ETIPRATE
Carcinoid syndrome (Partnership with Lexicon)
-
-
-
Completed in 2015/Early 2016
CABOZANTINIB
Renal cell carcinoma (Second line) (Partnership with Exelixis)
-
-
-
Completed in 2015/Early 2016
CABOZANTINIB
Hepatocellular carcinoma (Second line) (Partnership with Exelixis)
-
-
-
In progress in 2015
Neurosciences
Preclinical
Phase I
Phase II
Phase III
-
-
-
-
-
NOVEL BOTULINUM TOXIN
In progress in 2015
-
-
-
LRRK2
(Partnership with Oncodesign)
In progress in 2015
-
-
-
VSN 16R
Spasticity in multiple sclerosis (Study performed by Canbex under an option to acquire)
-
-
In progress in 2015
-
BN82451B
Huntington disease
-
-
In progress in 2015
-
DYSPORT®
Adult lower limb spasticity
-
-
-
In progress in 2015
DYSPORT®
Pediatric upper limb spasticity
-
-
-
In progress in 2015
DYSPORT® NEXT GENERATION
Glabellar lines
-
-
-
In progress in 2015
DYSPORT®
Glabellar lines
-
-
-
In progress in 2015
DYSPORT®
Pediatric lower limb spasticity
-
-
-
Completed in 2015/Early 2016
Endocrinology
Preclinical
Phase I
Phase II
Phase III
-
-
-
-
-
G PROTEIN-COUPLED RECEPTORS
In progress in 2015
-
-
-
BIM23B065 Cushing disease
-
Completed in 2015/Early 2016
-
-
SOMATULINE® PROLONGED RELEASE FORMULATION
Acromegaly
-
-
In progress in 2015
-
Last update 31/03/2016